Not applicableStudy completedNCT01843400What this trial is testingRegorafenib Post-marketing SurveillanceWho this might be right forColorectal Neoplasms Bayer 1,301
Testing effectiveness (Phase 2)Study completedNCT03519295What this trial is testingMDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal CarcinomaWho this might be right forAnal Cancer GERCOR - Multidisciplinary Oncology Cooperative Group 97
Early research (Phase 1)Study completedNCT00641615What this trial is testingPeptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal CancerWho this might be right forColorectal Cancer Kazuhiko Yoshimatsu 18
Testing effectiveness (Phase 2)Study completedNCT00003834What this trial is testingCombination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Alliance for Clinical Trials in Oncology 44
Testing effectiveness (Phase 2)Study completedNCT00056030What this trial is testingCombination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Alliance for Clinical Trials in Oncology 73
Testing effectiveness (Phase 2)Study completedNCT00668863What this trial is testingStudy Of Sunitinib With FOLFIRI In Colorectal CancerWho this might be right forUnresectable or Metastatic Colorectal Cancer Pfizer 71
Large-scale testing (Phase 3)Looking for participantsNCT06733038What this trial is testingFOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.Who this might be right forColorectal Cancer Gruppo Oncologico del Nord-Ovest 238
Large-scale testing (Phase 3)Study completedNCT02788279What this trial is testingInvestigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)Who this might be right forColorectal Cancer Hoffmann-La Roche 363
Not applicableStudy completedNCT05487248What this trial is testingOn-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer PatientsWho this might be right forUnresectable Locally Advanced Colorectal CancerMetastatic Colorectal CancerCandidate for Third-line or Subsequent Lines of Therapy Jules Bordet Institute 103
Early research (Phase 1)Not Yet RecruitingNCT07649655What this trial is testingEMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal CancerWho this might be right forUnresectable/Metastatic Colorectal Cancer Shanghai EpimAb Biotherapeutics Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT03711058What this trial is testingStudy of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal CancerWho this might be right forUnresectable or Metastatic Microsatellite Stable (MSS) Solid TumorMicrosatellite Stable (MSS) Colon Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Early research (Phase 1)Active Not RecruitingNCT05907304What this trial is testingAssess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X MutationsWho this might be right forAdvanced or Metastatic Solid Tumors Erasca, Inc. 86
Large-scale testing (Phase 3)UnknownNCT02102789What this trial is testingSystemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver MetastasisWho this might be right forMetastatic Colorectal Cancer Yuhong Li 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725What this trial is testingLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more Fred Hutchinson Cancer Center 50
Large-scale testing (Phase 3)Looking for participantsNCT06997497What this trial is testingA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Who this might be right forColon AdenocarcinomaRectal Adenocarcinoma Merck Sharp & Dohme LLC 477
Large-scale testing (Phase 3)Not Yet RecruitingNCT06959693What this trial is testingA Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)Who this might be right forMetastatic Colorectal Cancer (CRC) Sun Yat-sen University 590
Testing effectiveness (Phase 2)UnknownNCT05035381What this trial is testingPD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal CancerWho this might be right forMSI-H Advanced Colorectal Cancer Tianjin Medical University Cancer Institute and Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06885034What this trial is testingTest the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)Who this might be right forGastrointestinal Neoplasms GlaxoSmithKline 451
Large-scale testing (Phase 3)Looking for participantsNCT06509126What this trial is testingIntermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal CancerWho this might be right forColorectal Cancer Stage IV National Cancer Institute, Naples 500